Cylene Pharmaceuticals Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Cylene Pharmaceuticals General Information

Description

Developer of small molecule drugs designed to target against newly validated cancer. The company's small molecule drugs delivers first-in-class targeted agents that act through the ideal non-genotoxic pathway for activating p53 to kill cancer cells, enabling physicians to offer improved treatment outcomes against many cancer indications.

Contact Information

Formerly Known As
Cyternex, Cyternex Inc
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 5820 Nancy Ridge Drive
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 5820 Nancy Ridge Drive
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cylene Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Out of Business 01-Apr-2013 Completed Out of Business
8. Later Stage VC 18-Jan-2013 Completed Profitable
7. Later Stage VC (Series C) 27-Sep-2010 Completed Profitable
6. Grant 31-Dec-2009 Completed Profitable
5. Later Stage VC (Series C) 23-Jan-2007 Completed Profitable
4. Later Stage VC (Series B) 25-May-2005 Completed Profitable
3. Later Stage VC (Series A) 03-May-2004 Completed Profitable
2. Later Stage VC 24-Mar-2003 $1.22M $4.77M Completed Profitable
1. Early Stage VC (Series A) 17-Oct-2001 $3.55M $3.55M Completed Profitable
To view Cylene Pharmaceuticals’s complete valuation and funding history, request access »

Cylene Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 6,513,212 $0.001000 $0.08 $1 $1 1x $1 5.97%
To view Cylene Pharmaceuticals’s complete cap table history, request access »

Cylene Pharmaceuticals Patents

Cylene Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022179783-A Crystal forms of quinolone analogues and their salts Pending 28-Aug-2020
JP-2020189888-A Quinolone analog and form of salt thereof Inactive 28-Aug-2020
JP-2022020003-A Combination therapy of tetracyclic quinolone analogs to treat cancer Inactive 20-Nov-2015
WO-2012170827-A2 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors Inactive 08-Jun-2011
WO-2012054493-A1 Deuterated serine-threonine protein kinase modulators Inactive 22-Oct-2010 A61K31/44
To view Cylene Pharmaceuticals’s complete patent history, request access »

Cylene Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cylene Pharmaceuticals FAQs

  • When was Cylene Pharmaceuticals founded?

    Cylene Pharmaceuticals was founded in 1997.

  • Where is Cylene Pharmaceuticals headquartered?

    Cylene Pharmaceuticals is headquartered in San Diego, CA.

  • What is the size of Cylene Pharmaceuticals?

    Cylene Pharmaceuticals has 3 total employees.

  • What industry is Cylene Pharmaceuticals in?

    Cylene Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Cylene Pharmaceuticals a private or public company?

    Cylene Pharmaceuticals is a Private company.

  • What is Cylene Pharmaceuticals’s current revenue?

    The current revenue for Cylene Pharmaceuticals is .

  • How much funding has Cylene Pharmaceuticals raised over time?

    Cylene Pharmaceuticals has raised $106M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process